Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ivy Carroll

Showing results (61-70 of 186) with videos related to

Pageof 19
Sort By:
Pharmacology, Biochemistry, and Behavior|March 3, 2005
Interaction of cocaine and dopamine transporter inhibitors on behavior and neurochemistry in monkeysBrett C Ginsburg, Heather L Kimmel, F Ivy Carroll, et al.
The AAPS Journal|April 6, 2006
Development of the dopamine transporter selective RTI-336 as a pharmacotherapy for cocaine abuseF Ivy Carroll, James L Howard, Leonard L Howell, et al.
Neuropharmacology|June 4, 2018
New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in miceDeniz Bagdas, Yasmin Alkhlaif, Asti Jackson, et al.
British Journal of Pharmacology|September 27, 2016
Attenuated nicotine-like effects of varenicline but not other nicotinic ACh receptor agonists in monkeys receiving nicotine dailyColin S Cunningham, Megan J Moerke, Martin A Javors, et al.
Annals of the New York Academy of Sciences|November 19, 2011
Designer drugs: a medicinal chemistry perspectiveF Ivy Carroll, Anita H Lewin, S Wayne Mascarella, et al.
Life Sciences|October 12, 2013
Emergence and properties of spice and bath salts: a medicinal chemistry perspectiveAnita H Lewin, Herbert H Seltzman, F Ivy Carroll, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 2, 2013
Nicotinic receptor agonists reduce L-DOPA-induced dyskinesias in a monkey model of Parkinson's diseaseDanhui Zhang, Archana Mallela, David Sohn, et al.
Journal of Medicinal Chemistry|November 11, 2005
Synthesis and pharmacological characterization of exo-2-(2'-chloro-5-pyridinyl)-7-(endo and exo)-aminobicyclo[2.2.1]heptanes as novel epibatidine analoguesF Ivy Carroll, Lawrence E Brieaddy, Hernán A Navarro, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 2003
Distinct molecular recognition of psychostimulants by human and Drosophila serotonin transportersDavid L Roman, Shannon N Saldaña, David E Nichols, et al.
Brain Research|November 21, 2007
mGluR5 antagonists that block calcium mobilization in vitro also reverse (S)-3,5-DHPG-induced hyperalgesia and morphine antinociceptive tolerance in vivoBichoy H Gabra, Forrest L Smith, Hernán A Navarro, et al.
Pageof 19

Showing results (61-70 of 186) with videos related to

Sort By:
Pageof 19
Pharmacology, Biochemistry, and Behavior|March 3, 2005
Interaction of cocaine and dopamine transporter inhibitors on behavior and neurochemistry in monkeysBrett C Ginsburg, Heather L Kimmel, F Ivy Carroll, et al.
The AAPS Journal|April 6, 2006
Development of the dopamine transporter selective RTI-336 as a pharmacotherapy for cocaine abuseF Ivy Carroll, James L Howard, Leonard L Howell, et al.
Neuropharmacology|June 4, 2018
New insights on the effects of varenicline on nicotine reward, withdrawal and hyperalgesia in miceDeniz Bagdas, Yasmin Alkhlaif, Asti Jackson, et al.
British Journal of Pharmacology|September 27, 2016
Attenuated nicotine-like effects of varenicline but not other nicotinic ACh receptor agonists in monkeys receiving nicotine dailyColin S Cunningham, Megan J Moerke, Martin A Javors, et al.
Annals of the New York Academy of Sciences|November 19, 2011
Designer drugs: a medicinal chemistry perspectiveF Ivy Carroll, Anita H Lewin, S Wayne Mascarella, et al.
Life Sciences|October 12, 2013
Emergence and properties of spice and bath salts: a medicinal chemistry perspectiveAnita H Lewin, Herbert H Seltzman, F Ivy Carroll, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 2, 2013
Nicotinic receptor agonists reduce L-DOPA-induced dyskinesias in a monkey model of Parkinson's diseaseDanhui Zhang, Archana Mallela, David Sohn, et al.
Journal of Medicinal Chemistry|November 11, 2005
Synthesis and pharmacological characterization of exo-2-(2'-chloro-5-pyridinyl)-7-(endo and exo)-aminobicyclo[2.2.1]heptanes as novel epibatidine analoguesF Ivy Carroll, Lawrence E Brieaddy, Hernán A Navarro, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 2003
Distinct molecular recognition of psychostimulants by human and Drosophila serotonin transportersDavid L Roman, Shannon N Saldaña, David E Nichols, et al.
Brain Research|November 21, 2007
mGluR5 antagonists that block calcium mobilization in vitro also reverse (S)-3,5-DHPG-induced hyperalgesia and morphine antinociceptive tolerance in vivoBichoy H Gabra, Forrest L Smith, Hernán A Navarro, et al.
Pageof 19